{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:52:00Z","timestamp":1787316720731,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011772","name":"Novartis Farmac\u00e9utica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020604","name":"Novartis Farma SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020604","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijcrp.2025.200385","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T12:04:34Z","timestamp":1741262674000},"page":"200385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Lipid-lowering prescription patterns after a non-fatal acute coronary syndrome: A retrospective cohort study"],"prefix":"10.1016","volume":"25","author":[{"given":"Cristina","family":"Gavina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Seabra","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Afonso-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Sofia","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Canelas-Pais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Louren\u00e7o-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0998-6000","authenticated-orcid":false,"given":"Tiago","family":"Taveira-Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2025.200385_bib1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global Burden of cardiovascular diseases and risks collaborators. Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200385_bib2","unstructured":"Global Health Estimates: Life expectancy and leading causes of death and disability. [cited 21 Nov 2023]. Available: https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates."},{"key":"10.1016\/j.ijcrp.2025.200385_bib3","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200385_bib4","unstructured":"Estat\u00edsticas da Sa\u00fade - 2019. In: Portal do INE [Internet]. Available: https:\/\/www.ine.pt\/xportal\/xmain?xpid=INE&xpgid=ine_publicacoes&PUBLICACOESpub_boui=257483090&PUBLICACOEStema=55538&PUBLICACOESmodo=2."},{"key":"10.1016\/j.ijcrp.2025.200385_bib5","series-title":"Preval\u00eancia de fatores de risco cardiovascular na popula\u00e7\u00e3o portuguesa: Relat\u00f3rio estudo e_COR","author":"Bourbon","year":"2019"},{"key":"10.1016\/j.ijcrp.2025.200385_bib6","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200385_bib7","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200385_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.recesp.2021.10.016","volume":"75","author":"Visseren","year":"2022","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200385_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200385_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.atherosclerosis.2022.06.518","article-title":"Cardiovascular outcomes according to risk category: results of a retrospective database study","volume":"355","author":"Ara\u00fajo","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcrp.2025.200385_bib11","article-title":"Cardiovascular risk profile and lipid management in the population-based cohort study LATINO: 20 Years of real-world data","volume":"11","author":"Gavina","year":"2022","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.ijcrp.2025.200385_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ehjqcco\/qcy058","article-title":"Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data","volume":"5","author":"Lindh","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.ijcrp.2025.200385_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022198","article-title":"Event rates and risk factors for recurrent cardiovascular events and mortality in a contemporary post acute coronary syndrome population representing 239 234 patients during 2005 to 2018 in the United States","volume":"11","author":"Steen","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2025.200385_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12872-019-1231-z","article-title":"Incidence and risk factors for recurrent cardiovascular disease in middle-eastern adults: a retrospective study","volume":"19","author":"Govender","year":"2019","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcrp.2025.200385_bib15","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200385_bib16","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200385_bib17","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200385_bib18","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200385_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/eurheartj\/ehab718","article-title":"Combination lipid-lowering therapy as first-line strategy in very high-risk patients","volume":"43","author":"Ray","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200385_bib20","series-title":"Portal Do INE [Internet]","year":"2021"},{"key":"10.1016\/j.ijcrp.2025.200385_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7326\/M14-0126","article-title":"Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology\/American Heart Association cholesterol guideline","volume":"160","author":"Stone","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcrp.2025.200385_bib24","unstructured":"Online T. A High-Level grammar of interactive graphics. In: Vega-Lite [Internet]. [cited 2 Nov 2022]. Available: https:\/\/vega.github.io\/vega-lite\/."},{"key":"10.1016\/j.ijcrp.2025.200385_bib25","unstructured":"Therneau TM, Lumley T. Package \u201csurvival.\u201d R Top Doc. 2015;128: 28\u201333. Available: https:\/\/vps.fmvz.usp.br\/CRAN\/web\/packages\/survival\/survival.pdf."},{"key":"10.1016\/j.ijcrp.2025.200385_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1741826711400545","article-title":"Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada","volume":"19","author":"Gitt","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ijcrp.2025.200385_bib27","article-title":"Results of the dyslipidemia International study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment","volume":"9","author":"Al","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcrp.2025.200385_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.repc.2019.02.009","article-title":"DISGEN-LIPID study Investigators, Suboptimal lipid levels in clinical practice among Portuguese adults with dyslipidemia under lipid-lowering therapy: Data from the DISGEN-LIPID study","volume":"38","author":"da Silva","year":"2019","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.ijcrp.2025.200385_bib29","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study","volume":"28","author":"Ray","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ijcrp.2025.200385_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/eurheartj\/ehaa1011","article-title":"Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study","volume":"42","author":"Schubert","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200385_bib31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00392-017-1193-z","article-title":"Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins","volume":"107","author":"Fox","year":"2018","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200385_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186861","article-title":"Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? \u2012 Data from a multicenter registry cohort study in Taiwan","volume":"12","author":"Yeh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcrp.2025.200385_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12872-020-01616-9","article-title":"Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study","volume":"20","author":"Kristensen","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcrp.2025.200385_bib34","article-title":"Exploring contemporary data on lipid-lowering therapy prescribing in patients following discharge for atherosclerotic cardiovascular disease in the South of Italy","volume":"11","author":"Citarella","year":"2022","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.ijcrp.2025.200385_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2296-15-130","article-title":"The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review","volume":"15","author":"Lebeau","year":"2014","journal-title":"BMC Fam. Pract."},{"key":"10.1016\/j.ijcrp.2025.200385_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286376","article-title":"Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study","volume":"18","author":"Ersb\u00f8ll","year":"2023","journal-title":"PLoS One"}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:48:43Z","timestamp":1762645723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487525000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"alternative-id":["S2772487525000236"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200385","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-lowering prescription patterns after a non-fatal acute coronary syndrome: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200385"}}